FDA has increased the funding ceiling in its contract with Harvard Pilgrim Health Care for the Mini-Sentinel post-market safety surveillance project by $35 million to $135 million, the agency recently announced.
The increase is needed to support the larger-than-expected data resource that has been built by Harvard Pilgrim to support FDA...